The name is the button.

An agent writes the code now, and a human thumb hovers over Accept all a hundred times a day. The honest question of this decade is what, exactly, you just accepted. So I read the diff.

Eight years as a backend engineer in Stockholm, back in Tokyo since 2023, and I still ship something small most nights, usually badly. My one rule: the only real review of a model is the thing you built with it. That is why there is no leaderboard on this site.

Around a hundred and forty sources come through — the labs' own posts, the papers, the tools, the runtimes and languages nobody is watching yet, the chip under the demo, and the newsletters people actually forward. What is moving gets counted so the week reads at a glance, and every few days I explain one mechanism in plain words.

A story here is a headline, a short excerpt, one image and the link to whoever wrote it. We never reproduce the post; the images belong to their authors. A post written in Japanese appears in Japanese, exactly as it was published, and the link goes to the original.

— Yuki Halvorsen, Tokyo

← Accept All Archive

Hacker News (front)GitHub

Early progress on accelerating drug development with Claude

10.27

Article URL: https://www.anthropic.com/research/early-progress-drug-development Comments URL: https://news.ycombinator.com/item?id=50265609 Points: 154 # Comments…

Models & releases

Read at Hacker News (front) ↗

One letter a week, starting soon.

Latest

Early progress on accelerating drug development with Claude

Related

Toolsb11936 llama.cpp releases

ToolsRelease v0.67.0-preview.0 Gemini CLI releases

Alibaba's latest Qwen models routed some requests through company servers, researchers find The Decoder

SiliconCERN Partners With Mistral to Build a New Kind of AI for Physics HPCwire

ValleyDisruptive raises $10B fund to make big bets on at least 10 companies TechCrunch AI

VoicesHow Anthropic ships Claude with Claude: Separating the Brain from the Hands Latent Space